Home
LEO Pharma

LEO Pharma Market Share Analysis for June 2026

Industry: N/A

Domainleo-pharma.it

Year Founded1908

Employees1001 - 5000

Annual Revenue> $1B

LEO Pharma

LEO Pharma (including company regionals)

leo-pharma.it

See more website traffic and engagement information

LEO Pharma Revenue up to June 2026 is > 1B

revenue generated by LEO Pharma top domains

LEO Pharma top domains revenue over 3 years

Revenue for LEO Pharma top domains

leo-pharma.it> 1B

See more with Sales Intelligence

Total visits to LEO Pharma's top domains

Understand LEO Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

leo-pharma.it1.2K

See more with Sales Intelligence

Avg. visit duration in LEO Pharma's top domains

Analyze LEO Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

leo-pharma.it00:01:28

See more with Sales Intelligence

Avg. pageviews on LEO Pharma's top domains

See how LEO Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

leo-pharma.it2.67

See more with Sales Intelligence

LEO Pharma top competitors by domain

Top similar sites in June 2026, ranked by their affinity

idifarmaceutici.comCompany NameIDI FarmaceuticiEmployees201 - 500HQItaly, PomeziaAnnual revenue--Total visits1.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by LEO Pharma

These are the website technologies, by industry, used by LEO Pharma top domains

Social (5)

Instagram

Mobile (3)

Meta Viewport

Advertising (2)

DoubleClick

Audio Video Media (1)

YouTube

More Technologies

4

See all

News & Signals from LEO Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBayer AG sold assets to Leo Pharma on Jul 2nd '19.As announced as part of the agreement, LEO Pharma has now acquired the global product rights for Bayer’s global prescription dermatology business with the exception of Afghanistan and Pakistan.